Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Small nuclear ribonucleoprotein polypeptide C pseudogene 2 (SNRPCP2)
- Target
- SNRPCP2
- Molecular classification
- Other (Pseudogene)
01
Overview
Small nuclear ribonucleoprotein polypeptide C pseudogene 2 (SNRPCP2) is classified as a pseudogene, meaning it is a genomic DNA sequence similar to a gene but typically non-functional—it does not encode a protein and is generally not transcribed or translated. SNRPCP2 resembles the gene for small nuclear ribonucleoprotein polypeptide C (SNRPC), which is a component of the spliceosomal complex involved in mRNA splicing. However, as a pseudogene, SNRPCP2 does not produce a functional molecule, holds no known biological function, and is not considered a drug target. Pseudogenes can occasionally have regulatory roles or be evolutionary remnants, but there are no data supporting SNRPCP2 as a target in disease or therapy. Summary of key issues: - SNRPCP2 does not encode a functional receptor, enzyme, or protein. - It is a pseudogene and is not a therapeutic target or a molecule with drug interactions. - Its inclusion as a target is incorrect for most structured drug/gene target databases. If you require information on the functional protein (SNRPC) instead of the pseudogene, specify "small nuclear ribonucleoprotein polypeptide C (SNRPC)" for an appropriate target profile.
- Other names
- SNRPCP2small nuclear ribonucleoprotein C pseudogene 2
Beyond the preview
Go deeper on Small nuclear ribonucleoprotein polypeptide C pseudogene 2 (SNRPCP2).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Small nuclear ribonucleoprotein polypeptide C pseudogene 2 (SNRPCP2).